The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Alnylam Pharmaceuticals, Inc(NASDAQ:ALNY) 
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing RNA interference (RNAi) therapeutics. The company's pipeline of investigational RNAi therapeutics focus on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, an...
Website: http://www.alnylam.com
Founded: 2002
Full Time Employees: 1,323
Sector: Healthcare
Industry: Biotechnology
Alnylam Pharmaceuticals Days Payable Outstanding ttm (DPO)
Alnylam Pharmaceuticals Days Receivable Outstanding ttm (DSO)
Alnylam Pharmaceuticals Days Inventory Outstanding ttm (DIO)
Alnylam Pharmaceuticals Op Cashflow Per Share ttm
Alnylam Pharmaceuticals Free Cashflow Per Share ttm
Alnylam Pharmaceuticals Cash Per Share ttm
Alnylam Pharmaceuticals P/S ratio ttm
Alnylam Pharmaceuticals (GAAP) P/E ratio ttm
Alnylam Pharmaceuticals P/B ratio ttm
No extra charts and metrics for this ticker.